Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Dulaglutide in Obesity: NCT07652333 Clinical Landscape Report 2026
9 min read
Dulaglutide in Obesity: NCT07652333 Clinical Landscape Report 2026
16 October 2026
NCT07652333 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Olanzapine in Weight Loss: ACTRN12626000719336 Clinical Landscape Report 2026
9 min read
Olanzapine in Weight Loss: ACTRN12626000719336 Clinical Landscape Report 2026
16 October 2026
ACTRN12626000719336 clinical landscape for Weight Loss: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
LY4174794 (Eli Lilly & Co.) in Obesity: NCT07654972 Clinical Landscape Report 2026
9 min read
LY4174794 (Eli Lilly & Co.) in Obesity: NCT07654972 Clinical Landscape Report 2026
16 October 2026
NCT07654972 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Metformin Hydrochloride in Obesity: NCT07654179 Clinical Landscape Report 2026
9 min read
Metformin Hydrochloride in Obesity: NCT07654179 Clinical Landscape Report 2026
16 October 2026
NCT07654179 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Afatinib Dimaleate in Esophageal Squamous Cell Carcinoma: NCT07653451 Clinical Landscape Report 2026
9 min read
Afatinib Dimaleate in Esophageal Squamous Cell Carcinoma: NCT07653451 Clinical Landscape Report 2026
16 October 2026
NCT07653451 clinical landscape for Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
Read →
Mazdutide in Coronary Artery Disease: NCT07657676 Clinical Landscape Report 2026
9 min read
Mazdutide in Coronary Artery Disease: NCT07657676 Clinical Landscape Report 2026
16 October 2026
NCT07657676 clinical landscape for Coronary Artery Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Insulin aspart in Hearing Loss, Sudden: NCT07652528 Clinical Landscape Report 2026
9 min read
Insulin aspart in Hearing Loss, Sudden: NCT07652528 Clinical Landscape Report 2026
16 October 2026
NCT07652528 clinical landscape for Hearing Loss, Sudden: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Palmidrol in Obesity: NCT07652320 Clinical Landscape Report 2026
9 min read
Palmidrol in Obesity: NCT07652320 Clinical Landscape Report 2026
16 October 2026
NCT07652320 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Nanocurcumin in Squamous cell carcinoma of the oral cavity: CTRI/2026/06/113022 Clinical Landscape Report 2026
9 min read
Nanocurcumin in Squamous cell carcinoma of the oral cavity: CTRI/2026/06/113022 Clinical Landscape Report 2026
16 October 2026
CTRI/2026/06/113022 clinical landscape for Squamous cell carcinoma of the oral cavity: endpoints, sponsor, phase, geography, readouts, asset context and deve…
Read →
Selenium in Digestive System Disorders: PACTR202606863904065 Clinical Landscape Report 2026
9 min read
Selenium in Digestive System Disorders: PACTR202606863904065 Clinical Landscape Report 2026
16 October 2026
PACTR202606863904065 clinical landscape for Digestive System Disorders: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
Read →
BI-3034701 in Obesity: NCT07693231 Clinical Landscape Report 2026
9 min read
BI-3034701 in Obesity: NCT07693231 Clinical Landscape Report 2026
16 October 2026
NCT07693231 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Spermidine in Hyperlipidemias: NCT07662330 Clinical Landscape Report 2026
9 min read
Spermidine in Hyperlipidemias: NCT07662330 Clinical Landscape Report 2026
16 October 2026
NCT07662330 clinical landscape for Hyperlipidemias: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →